-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Target Site vs. Surrogate Site Biopsy for Diagnosis

Program: Special-Interest Sessions
Session: ASH Clinical Practice Guidelines on Amyloidosis
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Clinical Practice (Health Services and Quality), Diseases, Myeloid Malignancies
Sunday, December 8, 2024, 4:30 PM-6:00 PM

Angela Dispenzieri, MD

Mayo Clinic, Rochester, MN

Disclosures: Dispenzieri: Alexion: Consultancy, Research Funding; Takeda: Consultancy, Research Funding; BMS: Consultancy, Research Funding; Alnylam: Research Funding; Pfizer: Research Funding; Janssen: Research Funding; HaemaloiX: Research Funding.

See more of: ASH Clinical Practice Guidelines on Amyloidosis
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>